ijms-logo

Journal Browser

Journal Browser

Latest Advances in Diabetes Research and Practice

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Endocrinology and Metabolism".

Deadline for manuscript submissions: 20 December 2025 | Viewed by 570

Special Issue Editor


E-Mail Website
Guest Editor
School of Health & Medical Sciences, University of Southern Queensland, Toowoomba, Australia
Interests: diabetes mellitus; cardiovascular risk; metabolic syndrome; antioxidants; oxidative stress; diabetes self-management; cardiology; hypertension; insulin resistance; atherosclerosis; antiplatelet monitoring; preventive medicine; primary healthcare; community health; rural health; health promotion; evidence-based medicine; health economics; laboratory medicine

Special Issue Information

Dear Colleagues,

Diabetes mellitus has been a public health issues over the decades and continues to constitute clinical management challenges despite the growing research. The cardiovascular risk, and indeed related components of metabolic syndrome continue to confound both research and practice, such that the concept of diabetes self-management (DSM) has remained a subject of research elucidation. However, some success have been achieved in research and practice, including explications of:

  • Development: Oxidative stress and role of antioxidants at the molecular level
  • Progression: Cardiovascular risk and complications involving molecular and cellular basis
  • Management: Preventive medicines such as antiplatelet therapy and DSM
  • Monitoring: Role of laboratory medicine
  • Translation: applications in accessible and affordable pathology services

Giving cognizance to the above 5-themes, this special issue is inviting articles that provides updates or expands on latest advances in diabetes research and practice. Data on molecular mechanisms or pathophysiology are essential, and articles that expands on molecular science, laboratory medicine, or clinical practice will be very highly welcomed. The following types of articles can be submitted.

  1. Traditional narrative review of latest advances that follows the SANRA principles
  2. Systematic review that generates empirical and/or thematic summaries of latest advances
  3. Original research articles on molecular science, laboratory medicine, or clinical practice

Dr. Ezekiel Uba Nwose
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • diabetes mellitus
  • cardiovascular risk
  • metabolic syndrome
  • antioxidants
  • oxidative stress
  • antiplatelet monitoring
  • evidence-based medicine
  • laboratory medicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 411 KiB  
Article
Circulating Aryl Hydrocarbon Receptor Is Associated with Latent Tuberculosis Infection in Patients with Type 2 Diabetes
by Yu-Cheng Cheng, Wei-Chang Huang, Yu-Hsuan Li, Shin-Shin Liu, Meei-Ling Sheu and I-Te Lee
Int. J. Mol. Sci. 2025, 26(11), 5384; https://doi.org/10.3390/ijms26115384 - 4 Jun 2025
Viewed by 419
Abstract
Latent tuberculosis infection (LTBI) is prevalent in patients with type 2 diabetes. We aimed to examine the relationship between serum levels of aryl hydrocarbon receptor (AhR) and LTBI in patients with type 2 diabetes. In this cross-sectional study, patients with type 2 diabetes [...] Read more.
Latent tuberculosis infection (LTBI) is prevalent in patients with type 2 diabetes. We aimed to examine the relationship between serum levels of aryl hydrocarbon receptor (AhR) and LTBI in patients with type 2 diabetes. In this cross-sectional study, patients with type 2 diabetes were screened for LTBI using the QuantiFERON-TB (QFT) test. Of 543 patients screened for LTBI, 133 (24.5%) were QFT-positive. The QFT-positive patients had higher AhR levels than the QFT-negative patients (44.6 [interquartile range: 25.4–58.6] pg/mL vs. 37.8 [interquartile range: 17.4–55.0] pg/mL; p = 0.004). According to the receiver operating characteristic curve, the area under the curve was 0.584 (95% confidence interval: 0.528–0.639; p = 0.004) and the optimal cutoff value for serum AhR levels was of 37.7 pg/mL for differentiating a QFT-positive result. By a multivariable logistic regression analysis, the patients with high AhR levels had a greater risk of being QFT positive than those with low AhR levels (odds ratio = 1.902, 95% confidence interval: 1.254–2.886; p = 0.003). In conclusion, in patients with type 2 diabetes, a high serum AhR level was associated with LTBI. Full article
(This article belongs to the Special Issue Latest Advances in Diabetes Research and Practice)
Show Figures

Figure 1

Back to TopTop